FFIV
67
-2
PEG
57
4
TXN
43
-13
EQR
31
-2
ED
39
-11
COST
45
-3
DGX
53
3
DD
34
-2
VMC
60
-5
PFE
45
16
AMP
61
-2
CMA
52
-3
DVN
27
2
AA
34
2
EL
33
-3
ABBV
55
2
DE
46
-3
A
44
-2
PPL
69
2
TRV
49
-3
FFIV
67
-2
PEG
57
4
TXN
43
-13
EQR
31
-2
ED
39
-11
COST
45
-3
DGX
53
3
DD
34
-2
VMC
60
-5
PFE
45
16
AMP
61
-2
CMA
52
-3
DVN
27
2
AA
34
2
EL
33
-3
ABBV
55
2
DE
46
-3
A
44
-2
PPL
69
2
TRV
49
-3
Financhill
Back

Predictive Oncology 10K Form

Sell
22

POAI
Predictive Oncology

Last Price:
$0.98
Seasonality Move:
14.64%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-13 10Q POAI/Predictive Oncology Quarterly
2020-06-11 10Q POAI/Predictive Oncology Quarterly
2020-06-08 10Q POAI/Predictive Oncology Quarterly
2020-04-01 10K POAI/Predictive Oncology Annual
2019-11-15 10Q POAI/Predictive Oncology Quarterly
2019-08-19 10Q POAI/Predictive Oncology Quarterly

Receive POAI News And Ratings

See the #1 stock for the next 7 days that we like better than POAI

POAI Financial Statistics

Sales & Book Value

Annual Sales: $1.6M
Cash Flow: $-985.8K
Price / Cash Flow: 0
Annual Sales: $-0.02
Price / Book: 4.71

Profitability

EPS (TTM): -1.74000
Net Income (TTM): $-10.9M
Gross Margin: $797.7K
Return on Equity: -557.45%
Return on Assets: -137.73%

Predictive Oncology Earnings Forecast

Key Predictive Oncology Financial Ratios

  • The Gross Profit Margin over the past 17 years for POAI is 49.12%.
  • The Selling, General & Administrative Expenses for POAI have been equal to 547.23% of Gross Profit Margin.
  • The Research & Development expenses have been 187.66% of Revenue.
  • The Net Earning history of POAI is -779.91% of Total Revenues.
  • Per Share Earnings over the last 17 years have been positive in 14 years.

Predictive Oncology Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: POAI
CUSIP: 74039M
Website: predictive-oncology.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.76
Quick Ratio: 0.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

POAI Technical Analysis vs Fundamental Analysis

Sell
22
Predictive Oncology (POAI) is a Sell

Is Predictive Oncology a Buy or a Sell?